iatroX logo
brainstormaskiatroX
knowledge centreblog
Knowledge Centre / Cardiomyopathy (Restrictive)

Cardiomyopathy (Restrictive)

Overview and management of restrictive cardiomyopathy.

Reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP (General Practitioner)
Last reviewed: 21 October 2025
Cardiology

Clinical Guidelines

2023 ESC Guidelines for the management of cardiomyopathies
National
2019 HRS Expert Consensus Statement on Evaluation, Risk Stratification, and Management of Arrhythmogenic Cardiomyopathy
Local
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure
Local
2023 ESC Guidelines for the Management of Cardiomyopathies
Local
Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies
Local

Recent iatroX Q&As

  • Which investigations should be prioritized in a patient suspected of having restrictive cardiomyopathy?Updated: 8/22/2025
  • What are the current guidelines for the management and referral of patients with restrictive cardiomyopathy?Updated: 8/22/2025
  • What lifestyle modifications and pharmacological treatments are recommended for patients diagnosed with restrictive cardiomyopathy?Updated: 8/22/2025
askiatroX
privacytermshow it workscpdinsights
Download on the App StoreGet it on Google Play